• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰北部大疱性类天疱疮发病率的增加:奥卢大学医院的回顾性数据库研究。

Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital.

机构信息

Department of Dermatology, Oulu University Hospital, University of Oulu and Medical Research Center, Oulu, Finland.

出版信息

Br J Dermatol. 2014 Nov;171(5):1223-6. doi: 10.1111/bjd.13189. Epub 2014 Oct 19.

DOI:10.1111/bjd.13189
PMID:24934834
Abstract

BACKGROUND

Bullous pemphigoid (BP) is an autoimmune blistering skin disease of elderly people. Some studies have suggested that the incidence of BP has increased, but the diagnostic accuracy and methodology of studies have varied considerably.

OBJECTIVES

To examine the incidence of BP in Northern Finland, and whether the incidence has changed over time.

METHODS

This was a retrospective database study of all BP cases diagnosed in the Oulu University Hospital, Finland between 1985 and 2009. The diagnostic criteria were clinical features characteristic of BP (all patients) and positive direct or indirect immunofluorescence in the skin biopsy. The age-standardized incidences were calculated by the direct standardization method. Incidence rate ratios (IRR) were estimated by the Poisson regression model. To derive adjusted IRRs, age and sex were used as potential confounding factors.

RESULTS

The crude incidence of BP was 17 per 1 million person-years [95% confidence interval (CI) 15-20] between 1985 and 2009. Using the general European population as a reference, the age-standardized incidence was 14 per 1 million person-years (95% CI 12-17). The incidence of BP increased 1·8-fold (IRR 1·8, 95% CI 1·3-2·6; P < 0·001) in 2005-09 compared with the mean incidence of BP between 1985 and 2004, but after the adjustment for age and sex the increase was 1·4-fold (IRR 1·4, 95% CI 1·0-2·0; P = 0·043).

CONCLUSIONS

This is the first study with immunohistologically verified BP diagnoses that reports the increase in the incidence of BP in age- and sex-adjusted populations.

摘要

背景

大疱性类天疱疮(BP)是一种老年人自身免疫性水疱性皮肤病。一些研究表明,BP 的发病率有所增加,但研究的诊断准确性和方法差异很大。

目的

检查芬兰北部 BP 的发病率,以及发病率是否随时间发生变化。

方法

这是一项回顾性数据库研究,纳入了 1985 年至 2009 年间在芬兰奥卢大学医院诊断的所有 BP 病例。诊断标准为具有 BP 特征性的临床特征(所有患者)和皮肤活检的直接或间接免疫荧光阳性。采用直接标准化法计算年龄标准化发病率。采用泊松回归模型估计发病率比(IRR)。为了得出调整后的 IRR,年龄和性别被用作潜在的混杂因素。

结果

1985 年至 2009 年间,BP 的粗发病率为 17 例/100 万人年[95%可信区间(CI)15-20]。以普通欧洲人群为参照,年龄标准化发病率为 14 例/100 万人年(95% CI 12-17)。与 1985 年至 2004 年期间 BP 的平均发病率相比,2005-09 年 BP 的发病率增加了 1.8 倍(IRR 1.8,95% CI 1.3-2.6;P<0.001),但在调整年龄和性别后,发病率增加了 1.4 倍(IRR 1.4,95% CI 1.0-2.0;P=0.043)。

结论

这是第一项具有免疫组织化学验证的 BP 诊断的研究,报告了年龄和性别调整人群中 BP 发病率的增加。

相似文献

1
Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital.芬兰北部大疱性类天疱疮发病率的增加:奥卢大学医院的回顾性数据库研究。
Br J Dermatol. 2014 Nov;171(5):1223-6. doi: 10.1111/bjd.13189. Epub 2014 Oct 19.
2
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.瑞士大疱性类天疱疮和天疱疮的发病率:一项为期 2 年的前瞻性研究。
Br J Dermatol. 2009 Oct;161(4):861-8. doi: 10.1111/j.1365-2133.2009.09300.x. Epub 2009 May 8.
3
Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland.大疱性类天疱疮的死亡风险:芬兰的一项回顾性数据库研究
Acta Derm Venereol. 2016 Aug 23;96(6):758-61. doi: 10.2340/00015555-2347.
4
Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.苏格兰东北部格兰扁地区大疱性类天疱疮的年发病率和死亡率。
Br J Dermatol. 2005 Aug;153(2):424-7. doi: 10.1111/j.1365-2133.2005.06662.x.
5
Incidence and mortality of bullous pemphigoid in north-east Poland (Podlaskie Province), 1999-2012: a retrospective bicentric cohort study.1999 - 2012年波兰东北部(波德拉谢省)大疱性类天疱疮的发病率和死亡率:一项回顾性双中心队列研究
Int J Dermatol. 2014 Oct;53(10):e432-7. doi: 10.1111/ijd.12492. Epub 2014 Jul 11.
6
Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.大疱性类天疱疮患者静脉血栓栓塞风险增加。INVENTEP(大疱性类天疱疮静脉血栓栓塞发病率)研究。
Thromb Haemost. 2016 Jan;115(1):193-9. doi: 10.1160/TH15-04-0309. Epub 2015 Aug 6.
7
Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence.男性及高龄患者大疱性类天疱疮风险增加:一项基于人群的发病率研究
J Am Acad Dermatol. 1999 Aug;41(2 Pt 1):266-8. doi: 10.1016/s0190-9622(99)70061-7.
8
Incidence and mortality of bullous pemphigoid in France.法国大疱性类天疱疮的发病率和死亡率。
J Invest Dermatol. 2012 Aug;132(8):1998-2004. doi: 10.1038/jid.2012.35. Epub 2012 Mar 15.
9
Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.自身免疫性水疱病的酶联免疫吸附测定:卡利亚里皮肤科的初步经验
G Ital Dermatol Venereol. 2008 Feb;143(1):1-8.
10
Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases.2016 年德国北部天疱疮类疾病的发病率——来自石勒苏益格-荷尔斯泰因自身免疫性大疱性疾病登记处的首批数据。
J Eur Acad Dermatol Venereol. 2021 May;35(5):1197-1202. doi: 10.1111/jdv.17107. Epub 2021 Feb 10.

引用本文的文献

1
Bullous pemphigoid.大疱性类天疱疮
Nat Rev Dis Primers. 2025 Feb 20;11(1):12. doi: 10.1038/s41572-025-00595-5.
2
From Psychiatric Care to Dermatologic Dilemmas: A Case Report of Risperidone-Induced Bullous Pemphigoid.从精神科护理到皮肤科困境:一例利培酮诱发大疱性类天疱疮的病例报告
Cureus. 2024 Sep 10;16(9):e69125. doi: 10.7759/cureus.69125. eCollection 2024 Sep.
3
Accurate diagnosis of bullous pemphigoid requires multiple health care visits.大疱性类天疱疮的准确诊断需要多次就诊。
Front Immunol. 2023 Nov 27;14:1281302. doi: 10.3389/fimmu.2023.1281302. eCollection 2023.
4
Retrospective analysis of autoimmune bullous diseases in Middle Franconia.回顾性分析中弗兰肯地区的自身免疫性大疱性皮肤病。
Front Immunol. 2023 Oct 10;14:1256617. doi: 10.3389/fimmu.2023.1256617. eCollection 2023.
5
Bullous Pemphigoid Associated With Dipeptidyl Peptidase-4 Inhibitors: A Case Report and Review of Current Evidence.与二肽基肽酶-4抑制剂相关的大疱性类天疱疮:一例病例报告及当前证据综述
Hosp Pharm. 2023 Aug;58(4):357-362. doi: 10.1177/00185787231151861. Epub 2023 Feb 9.
6
The spectrum of skin-related conditions in primary care during 2015-2019-A Finnish nationwide database study.2015 - 2019年初级保健中皮肤相关疾病谱——一项芬兰全国性数据库研究
Skin Health Dis. 2021 Jun 5;1(3):e53. doi: 10.1002/ski2.53. eCollection 2021 Sep.
7
A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.大疱性类天疱疮相关免疫途径及新型治疗靶点综述
J Clin Med. 2022 May 18;11(10):2856. doi: 10.3390/jcm11102856.
8
Bullous pemphigoid associated with squamous cell lung carcinoma showing remarkable response to carboplatin-based chemotherapy:  a case report.大疱性类天疱疮伴鳞状细胞肺癌,对含卡铂的化疗有显著反应:病例报告。
J Med Case Rep. 2022 May 5;16(1):184. doi: 10.1186/s13256-022-03323-9.
9
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin.二肽基肽酶-4 抑制剂治疗的糖尿病患者并发大疱性类天疱疮:硬币的另一面。
J Transl Med. 2021 Dec 20;19(1):520. doi: 10.1186/s12967-021-03192-8.
10
Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.大疱性自身免疫性皮肤病——临床特征、诊断评估和治疗选择。
Dtsch Arztebl Int. 2021 Jun 18;118(24):413-420. doi: 10.3238/arztebl.m2021.0136.